Code summary
KBLI 47726 is the endpoint for Perdagangan Eceran Obat Farmasi Untuk Hewan. Use it only when the core business activity is genuinely perdagangan Eceran Obat Farmasi Untuk Hewan within group 477 and class 4772. Closest comparisons: 47725, 47727, 47724.
What belongs inside
Inside scope: perdagangan Eceran Obat Farmasi Untuk Hewan as the core activity.
What stays outside
Outside scope: perdagangan Eceran Alat Kesehatan Untuk Manusia, perdagangan Eceran Obat Tradisional Untuk Hewan, and other more accurate neighbouring endpoints.
Closest comparisons
- 47725 - Perdagangan Eceran Alat Kesehatan Untuk Manusia: Compare this code when the main activity is better described as perdagangan Eceran Alat Kesehatan Untuk Manusia rather than perdagangan Eceran Obat Farmasi Untuk Hewan.
- 47727 - Perdagangan Eceran Obat Tradisional Untuk Hewan: Compare this code when the main activity is better described as perdagangan Eceran Obat Tradisional Untuk Hewan rather than perdagangan Eceran Obat Farmasi Untuk Hewan.
- 47724 - Perdagangan Eceran Kosmetik Untuk Manusia: Compare this code when the main activity is better described as perdagangan Eceran Kosmetik Untuk Manusia rather than perdagangan Eceran Obat Farmasi Untuk Hewan.
| Level | Code | Description |
|---|---|---|
| Section | G | Wholesale and retail trade |
| Division | 47 | Perdagangan Eceran |
| Group | 477 | Perdagangan Eceran Barang Lainnya, Kecuali Mobil Dan Sepeda Motor |
| Class | 4772 | Perdagangan Eceran Bahan Dan Sediaan Farmasi, Alat Kesehatan, Parfum, Dan Kosmetik |
| Activity | 47726 | Perdagangan Eceran Obat Farmasi Untuk Hewan |
Sources
| Source | URL | Regulation | Tier |
|---|---|---|---|
| BPS KBLI 2025 | https://bps.go.id | BPS Regulation No. 7 of 2025 | official |
| Putranto Alliance KLU table | https://putranto-alliance.com/indonesian-business-field-classification-klu/ | Derived from DJP references | fallback |
This portal is informational. Confirm the final obligation and competent authority before filing, licensing, payroll, tax, or investment decisions. Read methodology.